Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Wuxi Biologics Cayman Inc (PK) WXIBF

Alternate Symbol(s):  WXXWY

Healthcare Biotechnology
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic... see more

Current News (PINL:WXIBF)

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates

PR Newswire June 9, 2021

Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines

PR Newswire October 10, 2020

WuXi Biologics Records Excellent Interim Results

PR Newswire August 17, 2020

WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer

PR Newswire August 6, 2020

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

PR Newswire August 4, 2020

Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day

PR Newswire June 19, 2020

WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing

PR Newswire June 15, 2020

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States

PR Newswire June 8, 2020

WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories

PR Newswire May 27, 2020
View More News ››

Opinion & Analysis (PINL:WXIBF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:WXIBF)

test

https://x.com/i/status/1893640093866377510 https://stockcharts.com/h-sc/ui
Blacknite4 - February 24, 2025

China News - WuXi Biologics and Tsinghua (EN & Chinese)

Not for distribution in US: China News Weekly 62 - WuXi Biologics and Tsinghua (EN & Chinese) https://nai500.com/blog/2018/05...
WesternInvestor - May 31, 2018
View more Bullboard ››

Diagnostear Technologies Inc

Diagnostear Technologies Inc

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic ...
View More »